These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 4608026)

  • 1. Two epipodophyllotoxin derivatives, VM 26 and VP 16213, in the treatment of leukemias, hematosarcomas, and lymphomas.
    Mathé G; Schwarzenberg L; Pouillart P; Oldham R; Weiner R; Jasmin C; Rosenfeld C; Hayat M; Misset JL; Musset M; Schneider M; Amiel JL; De Vassal F
    Cancer; 1974 Oct; 34(4):985-92. PubMed ID: 4608026
    [No Abstract]   [Full Text] [Related]  

  • 2. [Acute leukemia and various hematosarcomas. Trial treatment with a second derivative of podophyllotoxin (4-demethyl-epipodophyllotoxin beta D ethylidene glucoside VP 16213 or EPE)].
    Mathé G; Schwarzenberg L; Pouillart P; Weiner R; Oldham R; Jasmin C; Rosenfeld C; Hayat M; Schneider M; Amiel JL; Céoara B; Steresco-Musset M; de Vassal F
    Nouv Presse Med; 1974 Mar; 3(9):521-4. PubMed ID: 4595555
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapeutic trials in various hematosarcomas with 4-demethylepipo=dophyllotoxin-beta D thenylidene glucoside (VM 26 or EPT)].
    Mathé G; Schwarzenberg L; Pouillart P; Weiner R; Oldham R; Jasmin C; Rosenfeld ; Hayat M; Schneider M; Amiel JL; Céoara B; Steresco-Musset M; de Vassal F
    Nouv Presse Med; 1974 Feb; 3(8):447-51. PubMed ID: 4595690
    [No Abstract]   [Full Text] [Related]  

  • 4. Epipodophyllotoxin VP 16213 in treatment of acute leukaemias, haematosarcomas, and solid tumours.
    European Organization for Research on the Treatment of Cancer, Clinical Screening Group
    Br Med J; 1973 Jul; 3(5873):199-202. PubMed ID: 4578134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Initial results with a epipodophyllotoxin derivative VP 16-213 in the treatment of acute leukemia].
    Cavalli F; Ryssel HJ; Batz K; Sonntag RW; Brunner KW
    Schweiz Med Wochenschr; 1975 Feb; 105(8):250-3. PubMed ID: 1054886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4'-demethyl-epipodophyllotoxin-beta-D-thenylidene glucoside (VM-26)--a brief review.
    Goldsmith MA; Carter SK
    Eur J Cancer (1965); 1973 Jul; 9(7):477-82. PubMed ID: 4609765
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of VM 26 (epipodophyllotoxin) in treating acute leukemias and lymphomas in the adult].
    Kondrat'eva NA; Gershanovich ML; Kondrat'ev VB; Lebedev VN; Vygovskaia IaI
    Probl Gematol Pereliv Krovi; 1981 Jul; 26(7):10-4. PubMed ID: 7279889
    [No Abstract]   [Full Text] [Related]  

  • 8. [Combination of adriamycin, VM 26, cyclophosphamide and prednisone in the treatment of hematosarcomas].
    Laurens A; Thevenot J; Charron D; Jorry F; Dumonchel P; Martola R
    Ann Med Interne (Paris); 1977 May; 128(5):493-6. PubMed ID: 334012
    [No Abstract]   [Full Text] [Related]  

  • 9. [Personal experience on the chemotherapy of leukemias and hematosarcomas].
    Mathé G; Schneider M; Schwarzenberg L; Cattan A; Amiel JL; Schlumberger JR
    Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):245-54. PubMed ID: 4874537
    [No Abstract]   [Full Text] [Related]  

  • 10. [Results obtained with the clinical use of adriamycin].
    Esposito S; Taylor LA
    Haematologica; 1971; 56(9):343-66. PubMed ID: 5004536
    [No Abstract]   [Full Text] [Related]  

  • 11. [Results of a clinical study of an epipodophyllotoxin preparation (VM 26) in children with hemoblastoses].
    Kondrat'eva NA; Makhonova LA; Maiakova SA; Vialushkin BIa
    Probl Gematol Pereliv Krovi; 1981 Apr; 26(4):12-6. PubMed ID: 7015318
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapeutic progress and iatrogenic problems in malignant hemopathies].
    Geib KR; Papazian R
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1977; 29(4):343-9. PubMed ID: 22916
    [No Abstract]   [Full Text] [Related]  

  • 13. [Acute monocytic leukemia and acute myelomonocytic leukemia: treatment using VP 16213].
    Amiel JL; Schwarzenberg L; Musset M; De Vassal F; Hayat M; Mathé G
    Bull Cancer; 1974; 61(3):419-26. PubMed ID: 4533742
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapeutic trials with VP-16-213 and VM-26: active agents in small cell lung cancer, non-Hodgkin's lymphomas, and other malignancies.
    Radice PA; Bunn PA; Ihde DC
    Cancer Treat Rep; 1979 Aug; 63(8):1231-9. PubMed ID: 225026
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical results of treatment with E. coli L-asparaginase in adults with leukemia, lymphoma, and solid tumors.
    Clarkson B; Krakoff I; Burchenal J; Karnofsky D; Golbey R; Dowling M; Oettgen H; Lipton A
    Cancer; 1970 Feb; 25(2):279-305. PubMed ID: 4905154
    [No Abstract]   [Full Text] [Related]  

  • 16. Experience with 4'-demethylepipodo-phyllotoxin 9-(4,6-o-2-thenylidene-beta-D-glucopyranoside); VM-26; NSC-122819 in the treatment of malignant lymphosis.
    Sonntag RW; Senn HJ; Nagel G; Giger K; Alberto P
    Eur J Cancer (1965); 1974 Feb; 10(2):93-8. PubMed ID: 4611772
    [No Abstract]   [Full Text] [Related]  

  • 17. [Phase II study of etoposide (VP-16) in the form of intravenous injection for malignant lymphomas and acute leukemias: Hanshin Cooperative Study Group for Hematological Disorders].
    Tagawa S; Kitani T; Nagai K; Kanamaru A; Kohsaki M; Masaoka T; Shibata H; Horiuchi A; Tsubaki K; Kawagoe H
    Gan No Rinsho; 1987 Jan; 33(1):1-7. PubMed ID: 3469424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of chlorambucil and streptonigrin (NSC-45383) in the treatment of malignant lymphomas.
    Kaung DT; Wittington RM; Spencer H; Patno ME
    Cancer; 1969 Jun; 23(6):1280-3. PubMed ID: 4890442
    [No Abstract]   [Full Text] [Related]  

  • 19. A clinical trial of adriamycin in the malignant lymphomas.
    Cimo PL; Rudders RA; Hensleigh D
    Cancer; 1974 Nov; 34(5):1571-5. PubMed ID: 4609593
    [No Abstract]   [Full Text] [Related]  

  • 20. Epipodophyllotoxin (VP 16-213) in the treatmetn of diffuse histiocytic lymphoma.
    S Afr Med J; 1975 Mar; 49(13):483-5. PubMed ID: 167460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.